Table 1.
Significant associations between cancer gene eQTL and global tumor mutations
| eQTL |
Association results with TMB or TMC |
Association results with gene expression from GTExa |
|||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cancer type | Region | Lead SNP | Posb | Effect allele | Other allele | EAF | Beta | SE | P value | Gene | Beta (FE) | P value (FE) | Beta (RE) | P value (RE) | P value (RE2) |
| TMB of all cancer genes on OncoPanel | |||||||||||||||
| Ovarian Cancer | 2q14.2 | rs1530578 | 121702128 | T | C | 0.01 | 17.61 | 3.02 | 1.26E-08 | GLI2 | −0.11 | 2.41E-16 | −0.11 | 2.00E-10 | 1.33E-16 |
| Glioma | 8p12 | rs139944315 | 30332577 | T | A | 0.99 | −16.36 | 2.65 | 1.21E-09 | WRN | −0.30 | 6.35E-44 | −0.28 | 4.16E-20 | 6.79E-45 |
| Esophagogastric Carcinoma | 16q22.1 | rs11075646 | 66969176 | C | G | 0.90 | −2.57 | 0.53 | 1.48E-06 | CBFB | 0.05 | 2.06E-12 | 0.05 | 1.34E-08 | 3.03E-12 |
| TMC of recurrently mutated cancer genes | |||||||||||||||
| Colorectal Cancer | 4q13.2 | rs10031417 | 66700879 | A | G | 0.55 | −0.18 | 0.04 | 2.04E-06 | EPHA5 | 0.03 | 5.63E-05 | 0.03 | 4.12E-02 | 6.36E-13 |
| Endometrial Cancer | 5q22.2 | rs397768 | 112181576 | G | A | 0.38 | 0.24 | 0.05 | 1.43E-05 | APC | 0.01 | 7.91E-02 | 0.00 | 7.36E-01 | 3.77E-10 |
| Endometrial Cancer | 8p12 | rs11782945 | 31082006 | G | A | 0.41 | 0.58 | 0.12 | 4.95E-07 | WRN | 0.06 | 1.06E-26 | 0.06 | 4.95E-21 | 3.14E-26 |
| Endometrial Cancer | 12q13.3 | rs73115907 | 57754701 | G | A | 0.76 | −0.31 | 0.06 | 4.61E-07 | GLI1 | −0.02 | 2.75E-03 | −0.02 | 1.31E-01 | 2.99E-08 |
| Endometrial Cancer | 16q24.3 | rs7201264 | 90036122 | C | G | 0.20 | 0.41 | 0.07 | 1.10E-08 | FANCA | −0.07 | 4.70E-18 | −0.09 | 1.32E-07 | 8.17E-41 |
| Endometrial Cancer | 17p13.1 | rs17884306 | 7572101 | C | T | 0.94 | −0.60 | 0.13 | 4.36E-06 | TP53 | 0.09 | 2.41E-16 | 0.08 | 4.45E-12 | 8.15E-16 |
Meta-analysis results of the associations between the eQTL and normalized gene expression levels across 49 tissues
Position based on GRCh37/hg19